Ligand Launches Bazedoxifene in Japan and Spain

Ligand Pharmaceuticals Incorporated Wednesday announced that its partner Pfizer, Inc. launched Viviant (Bazedoxifene) in Japan for the treatment of postmenopausal osteoporosis.
TheStreet